PHAT Assurance turns programme evidence into a diagnostic view designed to answer the questions conventional programme reporting often cannot: where are we genuinely vulnerable, why, what happens if we do nothing, and where should leadership intervene first?
A concise programme-level conclusion, domain health profile and evidence visibility — independent of the programme's own RAG reporting.
The conditions that materially threaten delivery, business outcome, cost or readiness — prioritised above ordinary programme noise.
Apparently separate observations are connected into patterns showing how weaknesses in one part of the delivery system may amplify risk elsewhere.
PHAT distinguishes symptoms from the conditions driving them and shows how upstream weaknesses can create downstream consequences.
Leadership can see whether conclusions are supported by demonstrated evidence, partial evidence, unverified claims, or no supporting evidence.
Prioritised containment and remediation actions translate the diagnosis into interventions most likely to improve the programme outcome.
Reported programme status: AMBER/GREEN
Executive conclusion. The programme remains recoverable and no single issue independently requires a reset. However, interacting weaknesses across data, testing, process ownership and governance materially reduce confidence in the planned UAT and deployment dates.
It identifies what is driving it, the potential consequences downstream, and where intervention can make the greatest difference.
Testing: Amber
Data: Amber
Business readiness: Green
Each workstream can be rationally reported in isolation while the programme-level consequence remains obscured.
The apparent testing problem is partly a downstream consequence of unresolved data and design conditions, while the reported readiness position is not sufficiently supported by evidence.
Treating the testing symptoms alone is unlikely to recover the position. Leadership attention should first address the upstream conditions and establish whether the current go-live assumption remains credible.
Several individually manageable weaknesses combine to create a materially greater delivery exposure. Evidence indicates dependencies between unresolved solution decisions, data readiness and the remaining test window.
The programme may continue to report progress while consuming the contingency required to resolve problems already entering the downstream delivery path.
Demonstrated: 4 areas
Partial: 3 areas
Claimed / unverified: 2 areas
Not seen: 1 area
Validate the remaining critical path against demonstrated rather than reported readiness, establish the recovery capacity available within the current plan, and determine whether the programme can still achieve the intended outcome without unacceptable compromise.
Illustrative output. The underlying criteria, diagnostic relationships, weighting, thresholds and causal inference methodology are proprietary to PHAT and are intentionally not reproduced here.
PHAT connects apparently separate programme conditions to show how an upstream weakness can propagate into consequential delivery exposure.
Accountability gaps leave critical decisions unmade or unresolved.
Ambiguity drives rework, workarounds and misalignment.
Unstable builds and inconsistent testing erode confidence and hide defects.
Issues accumulate faster than they can be fixed as time tightens.
Defects, delay and operational disruption become increasingly likely.
Illustrative causal chain only. PHAT's diagnostic relationships and inference logic are not exposed in the public output.
Is the intended business outcome safe, what threatens it, and who owns the necessary remediation?
Where should I intervene, what should I verify, and what needs fixing first?
Is this programme on track to deliver to budget, and which current conditions might create additional cost?
Which assurances are supported by evidence, and where are we relying on assertion?
Does the organisation have the commitment, capability and capacity to own business readiness and land the change?
How can a repeatable ERP-specific diagnostic strengthen expert reviewer judgement, improve consistency and add value to the executive conversation?
See how Independent Assurance can turn evidence into a clearer view of programme health, causes and executive action.